National Cancer Institute / Phase II SBIR (R44CA239940)
Part of National Cancer Institute
The National Cancer Institute is the U.S. federal government's principal agency for cancer research, funding early-stage biomedical companies through its SBIR/STTR grant and contract program to advance cancer detection, treatment, and prevention technologies.
National Cancer Institute / Phase II SBIR (R44CA239940) was founded in 1937, is headquartered in Rockville, and has 1 recorded investment.
- Headquarters
- Rockville
- Founded
- 1937
- Website
- cancer.gov
- Total Investment
- 1
- Last Investment
- Sep 2021
- Geographic Focus
- United States
Indexed holds 1 funding round for this investor. The full record is or through the API.
Investment Thesis
National Cancer Institute / Phase II SBIR (R44CA239940) is a Government firm based in Rockville. It was founded in 1937. It has made 1 investment. Focus areas include Biotech.
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/national-cancer-institute-phase-ii-sbir-r44ca239940"><img src="https://indexed.vc/api/badge/investor/national-cancer-institute-phase-ii-sbir-r44ca239940" alt="National Cancer Institute / Phase II SBIR (R44CA239940) on Indexed.vc" width="260" height="76" /></a>